glp 1 analogue weight loss GLP-1 receptor agonists for reduction in people living with obesity but without diabetes: a living benefit–harm modelling study GLP-1 and Anesthesia: Considerations and

Efficacy and effectiveness of carnitine supplementation for cancer-related fatigue: a systematic literature review and meta-analysis

The starting dose considerations from your tirzepatide experience still inform your approach, but conservatism serves you well here

Fibroblast growth factor 21 protects against cardiac hypertrophy in mice

With advancing technologies like miRNA expression profiling and synthetic biology approaches, flavonoids hold potential as an innovative therapeutic strategy for managing cardiovascular disease, and they may also open avenues for the development of personalized treatments based on individual miRNA profiles

Fosgonimeton failed its Phase 2 ACT-AD trial in 2022 and its Phase 2/3 LIFT-AD trial in September 2024